Immunobiological medicine
Showing 1 - 25 of 6,905
Program, Double-blind, Placebo-controlled to Study Preventive
Completed
- Coronavirus Infections
- +2 more
-
Kirov, Russian FederationFederal State Budgetary Educational Institution of Higher Educat
Jul 8, 2022
Vaccine Trial in Russian Federation (Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for
Active, not recruiting
- Vaccine
- Vaccine for intramuscular injection
- Placebo comparator (without active ingredient) for intramuscular injection
-
Elektrostal, Moscow, Russian Federation
- +3 more
Feb 7, 2023
COVID-19 Pneumonia, COVID-19 Respiratory Infection, Covid19 Trial in Ciudad Autónoma De Buenos Aires (Anti-SARS-CoV-2, Placebo)
Recruiting
- COVID-19 Pneumonia
- +2 more
- Anti-SARS-CoV-2
- Placebo
-
Ciudad Autónoma De Buenos Aires, ArgentinaHospital General de Agudos Donación Francisco J. Santojanni
Sep 11, 2021
Coronavirus Infections, Vaccine Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated purified)
Recruiting
- Coronavirus Infections
- Vaccine
- CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
- The data from volunteers from the control group
-
Kirov, Russian Federation
- +9 more
Jul 8, 2022
Coronavirus Infections, Vaccine Trial in Russian Federation (Vaccine for intramuscular injection, Placebo comparator (without
Completed
- Coronavirus Infections
- Vaccine
- Vaccine for intramuscular injection
- Placebo comparator (without active ingredient) for intramuscular injection
-
Kirov, Russian Federation
- +4 more
Nov 11, 2021
COVID-19 Trial in Rio de Janeiro (Covid -19 (recombinante) vaccine)
Recruiting
- COVID-19
- Covid -19 (recombinante) vaccine
-
Rio de Janeiro, BrazilUnidade de Ensaios Clínicos em Imunobiológicos
Dec 1, 2021
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Neonatal Opiate Withdrawal Syndrome Trial in United States (Symptom-based Dosing Approach, Scheduled Opioid Taper Approach)
Not yet recruiting
- Neonatal Opiate Withdrawal Syndrome
- Symptom-based Dosing Approach
- Scheduled Opioid Taper Approach
-
Birmingham, Alabama
- +8 more
Jul 27, 2023
Obesity or Overweight Trial in China (Cagrilintide, Semaglutide, Placebo Semaglutide)
Not yet recruiting
- Obesity or Overweight
- Cagrilintide
- +3 more
-
Beijing, Beijing, China
- +24 more
Aug 10, 2023
Long COVID Trial (Traditional Chinese medicine treatment, Western medicine treatment)
Not yet recruiting
- Long COVID
- Traditional Chinese medicine treatment
- Western medicine treatment
- (no location specified)
Oct 25, 2023
Patient Care Team, Psychological Well-Being, Occupational Burnout Trial in United States (Team-building processes)
Not yet recruiting
- Patient Care Team
- +2 more
- Team-building processes
-
Ann Arbor, Michigan
- +4 more
Aug 24, 2023
Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Cagrilintide
- +3 more
-
Birmingham, Alabama
- +331 more
Sep 26, 2023
Healthy Volunteers, Dyslipidaemia Trial in Cypress (NNC0491-6075, Placebo)
Recruiting
- Healthy Volunteers
- Dyslipidaemia
- NNC0491-6075
- Placebo
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Aug 8, 2023
Healthy Participants Trial in New Haven (PF-06954522, Placebo)
Not yet recruiting
- Healthy Participants
- PF-06954522
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Aug 15, 2023
Healthy Participants Trial in Neuss (NNC0113-6856, Placebo)
Not yet recruiting
- Healthy Participants
- NNC0113-6856
- Placebo
-
Neuss, GermanyNovo Nordisk Investigational Site
Sep 29, 2023
Cardiovascular Diseases Trial in Ruddington (AZD0780 tablet, [14C]AZD0780 Solution for Infusion, [14C]AZD0780 Oral Solution)
Not yet recruiting
- Cardiovascular Diseases
- AZD0780 tablet
- +2 more
-
Ruddington, United KingdomResearch Site
Apr 5, 2023
Asthma Trial in Ruddington (AZD4604 Inhalation Powder, 1 mg, [14C]AZD4604 Solution for Infusion 6 µg/mL (NMT 37.0 kBq/5 mL),
Not yet recruiting
- Asthma
- AZD4604 Inhalation Powder, 1 mg
- +2 more
-
Ruddington, United KingdomQuotient Sciences Limited
Nov 27, 2023
COVID-19 Pneumonia Trial in Beijing (conventional western medicine treatment, Dexamethasone oral tablet, Traditional Chinese
Recruiting
- COVID-19 Pneumonia
- conventional western medicine treatment
- +2 more
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Apr 2, 2023
Obesity or Overweight Trial in Japan, Taiwan (Cagrilintide, Semaglutide, Placebo Semaglutide)
Not yet recruiting
- Obesity or Overweight
- Cagrilintide
- +2 more
-
Koriyama-shi, Fukushima, Japan, Japan
- +21 more
Apr 3, 2023
Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors Trial in Worldwide (Concizumab)
Active, not recruiting
- Haemophilia A Without Inhibitors
- Haemophilia B Without Inhibitors
-
Los Angeles, California
- +88 more
Feb 2, 2023
Post-COVID-19 Syndrome Trial (Complementary self-help strategies in addition to treatment as usual, Treatment as usual)
Not yet recruiting
- Post-COVID-19 Syndrome
- Complementary self-help strategies in addition to treatment as usual
- Treatment as usual
- (no location specified)
Apr 6, 2023
Hypertension, Blood Pressure Trial in Chicago (USeeBP)
Recruiting
- Hypertension
- Blood Pressure
- USeeBP
-
Chicago, IllinoisUniversity of Chicago
Oct 5, 2023
Polycystic Ovary Syndrome Trial in Nanchang (Bushen Huatan Decoction, Placebo)
Recruiting
- Polycystic Ovary Syndrome
- Bushen Huatan Decoction
- Placebo
-
Nanchang, Jiangxi, ChinaThe Second Affiliated Hospital of Jiangxi University of Traditio
Aug 4, 2023